These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 7648932)
1. [Drug therapy of gastrointestinal motility disorders]. Jia B Zhonghua Nei Ke Za Zhi; 1995 Mar; 34(3):151-2. PubMed ID: 7648932 [No Abstract] [Full Text] [Related]
2. Gastric emptying in gastroesophageal reflux and the therapeutic role of prokinetic agents. McCallum RW Gastroenterol Clin North Am; 1990 Sep; 19(3):551-64. PubMed ID: 1977702 [TBL] [Abstract][Full Text] [Related]
3. Use of metoclopramide, domperidone, and cisapride in the management of diabetic gastroparesis. Brown CK; Khanderia U Clin Pharm; 1990 May; 9(5):357-65. PubMed ID: 2190745 [TBL] [Abstract][Full Text] [Related]
4. The current status of gastric prokinetic drugs. Schapira M; Henrion J; Heller FR Acta Gastroenterol Belg; 1990; 53(4):446-57. PubMed ID: 1982914 [TBL] [Abstract][Full Text] [Related]
7. Cisapride--more selective than metoclopramide. Drug Ther Bull; 1990 Nov; 28(23):89-90. PubMed ID: 2131232 [No Abstract] [Full Text] [Related]
8. [Gastroesophageal reflux in the newborn]. Urrusti-Sanz J Gac Med Mex; 1995; 131(5-6):601-3. PubMed ID: 8768609 [No Abstract] [Full Text] [Related]
9. [Pharmacologic and clinical differentiation of prokinetic drugs]. May B; Greving I Leber Magen Darm; 1996 Jul; 26(4):193-8. PubMed ID: 8965601 [TBL] [Abstract][Full Text] [Related]
10. Cisapride, metoclopramide, and ranitidine in the treatment of severe nonulcer dyspepsia. Archimandritis A; Tzivras M; Fertakis A; Emmanuel A; Laoudi F; Kalantzis N; Anthopoulou H; Michailidis D Clin Ther; 1992; 14(4):553-61. PubMed ID: 1525789 [TBL] [Abstract][Full Text] [Related]
11. [A drive substance for the motor in digestion. Introduction]. Demling L Fortschr Med Suppl; 1990; 87():4. PubMed ID: 2351358 [No Abstract] [Full Text] [Related]
12. [The typical patient with disorder of digestive motility]. Demling L Fortschr Med Suppl; 1990; 87():17-9. PubMed ID: 2351357 [No Abstract] [Full Text] [Related]
13. Use of prokinetic agents in special populations. Horn JR Am J Health Syst Pharm; 1996 Nov; 53(22 Suppl 3):S27-9. PubMed ID: 8931828 [TBL] [Abstract][Full Text] [Related]
14. [Encouragement for the tired stomach. Cisapride, a specific pro-kinetic drug for upset stomach]. Fortschr Med Suppl; 1990; 87():7-12. PubMed ID: 2351360 [No Abstract] [Full Text] [Related]
15. [Cisapride: clinical experience in 1071 patients with non-ulcer dyspepsia or reflux symptoms]. Fehr HF Schweiz Med Wochenschr; 1991 Jun; 121(22):843-6. PubMed ID: 2063165 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of chronic-obstructive upper abdominal complaints. Outlook. Further hypothetical indications]. Fortschr Med Suppl; 1990; 87():15-6. PubMed ID: 2190899 [No Abstract] [Full Text] [Related]
17. Study with two prokinetics in functional dyspepsia and GORD: domperidone vs. cisapride. Halter F; Staub P; Hammer B; Guyot J; Miazza BM J Physiol Pharmacol; 1997 Jun; 48(2):185-92. PubMed ID: 9223023 [TBL] [Abstract][Full Text] [Related]
18. Cisapride and metoclopramide in the treatment of gastroesophageal reflux disease. Arabehety JT; Leitão OR; Fassler S; Olarte M; Serrano C Clin Ther; 1988; 10(4):421-8. PubMed ID: 3079010 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of cisapride in functional dyspepsia resistant to domperidone or metoclopramide: a double-blind, placebo-controlled study. Van Outryve M; De Nutte N; Van Eeghem P; Gooris JP Scand J Gastroenterol Suppl; 1993; 195():47-52; discussion 52-3. PubMed ID: 8516658 [TBL] [Abstract][Full Text] [Related]
20. [A retrospective study on the efficacy of the treatment of functional dyspepsia. An evaluation of 166 cases]. Canepa G; Di Somma C; Arnulfo G; Frascio M; Berti Riboli E Minerva Med; 1991 Jun; 82(6):371-3. PubMed ID: 2067709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]